From October 1, 2022 to October 25, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.09 CNY | -0.98% | -1.46% | +15.41% |
04-29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
04-29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.41% | 4.31B | |
+17.72% | 71.72B | |
-2.18% | 24.29B | |
+7.71% | 8.31B | |
-19.61% | 8.22B | |
+1.47% | 8.16B | |
+5.56% | 4.76B | |
-0.87% | 4.1B | |
+23.20% | 3.78B | |
+6.89% | 3.36B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.